Study: Resiniferatoxin may increase sepsis-related mortality
Wednesday, April 27, 2011 - 10:00
in Health & Medicine
Pain researchers from the Sheikh Zayed Institute for Pediatric Surgical Innovation at Children's National Medical Center have discovered that resiniferatoxin, a drug that has shown early promise as an option for chronic, severe pain sufferers, may decrease the body's ability to fight off bacterial infections, particularly sepsis.